AstraZeneca: Phase 3 trial of covid vaccine in US confirmed efficacy

AstraZeneca confirmed on Wednesday that its COVID-19 vaccine was very effective at preventing the disease.

The Anglo-Swedish drugmaker confirmed this based on more recent data after questions were raised on the interim results of its US clinical trial findings announced on Monday.

Key takeaways

“Positive high-level results from the primary analysis of the phase III trial of AZD1222 in the US have confirmed covid vaccine efficacy.”

“Vaccine well-tolerated, and no safety concerns were identified.”

“76% vaccine efficacy against symptomatic covid.”